Authors: Toshiyuki Nakanishi; Tsuneaki Kenzaka · Research
What Is Stiff-Person Syndrome and How Can It Be Misdiagnosed?
A case study exploring stiff-person syndrome, its symptoms, and how it can be mistaken for other conditions.
Source: Nakanishi, T., & Kenzaka, T. (2021). Stiff-person syndrome with rhabdomyolysis. BMJ Case Reports, 14, e246147. https://doi.org/10.1136/bcr-2021-246147
What you need to know
- Stiff-person syndrome (SPS) is a rare neurological disorder characterized by muscle stiffness and spasms
- SPS can be misdiagnosed as a psychiatric condition, especially if the patient is taking psychiatric medications
- Proper diagnosis and treatment of SPS can significantly improve a patient’s quality of life
Understanding Stiff-Person Syndrome
Stiff-person syndrome (SPS) is an uncommon neurological disorder that affects the central nervous system. It is caused by an autoimmune reaction, where the body’s immune system mistakenly attacks its own tissues. In SPS, this autoimmune response targets certain proteins in the nervous system, leading to the characteristic symptoms of the condition.
Key Symptoms
The main symptoms of SPS include:
- Progressive muscle stiffness, particularly in the limbs and trunk
- Episodic muscle spasms triggered by sudden stimuli like touch, noise, or light
- Difficulty walking and impaired mobility
- Exaggerated lumbar lordosis (an inward curve of the lower back)
These symptoms can significantly impact a person’s daily life, often leading to social isolation and anxiety due to fear of falling or being unable to move properly.
The Challenge of Diagnosis
One of the key issues highlighted in this case study is the potential for misdiagnosis of SPS. There are several reasons why SPS can be challenging to diagnose:
1. Similarity to Other Conditions
The symptoms of SPS can resemble those of other neurological or psychiatric disorders. In this case, the patient was initially thought to have neuroleptic malignant syndrome (NMS), a rare but serious reaction to certain medications used to treat mental health conditions.
2. Presence of Psychiatric Medications
If a patient with SPS is taking psychiatric medications, as was the case with this patient who was on a selective serotonin reuptake inhibitor (SSRI), it can further complicate the diagnosis. The muscle stiffness and spasms might be mistakenly attributed to side effects of the medication or to conditions like NMS or serotonin syndrome.
3. Elevated Creatine Kinase Levels
In some cases of SPS, including this one, blood tests may show high levels of creatine kinase (CK), an enzyme that can indicate muscle damage. While elevated CK is more commonly associated with conditions like NMS or rhabdomyolysis (severe muscle breakdown), this case demonstrates that it can also occur in SPS when muscle spasms are severe enough to cause muscle damage.
The Importance of Proper Diagnosis
Correctly diagnosing SPS is crucial for several reasons:
Appropriate treatment: The treatments for SPS (such as immune therapies and muscle relaxants) differ from those for psychiatric conditions or other neurological disorders.
Quality of life: With proper treatment, many SPS patients can experience significant improvement in their symptoms and overall functioning.
Avoiding unnecessary treatments: Misdiagnosis can lead to ineffective treatments that may have side effects without providing any benefit.
Diagnostic Clues for SPS
While diagnosing SPS can be challenging, there are several key indicators that healthcare providers should look for:
Characteristic muscle stiffness and spasms, especially in the trunk and limbs
Spasms triggered by sudden stimuli (touch, noise, light)
Presence of anti-glutamic acid decarboxylase (anti-GAD) antibodies in the blood
Oligoclonal bands in the cerebrospinal fluid (indicating an immune response in the central nervous system)
Improvement with specific treatments like diazepam (a muscle relaxant) or immune therapies
Treatment Approaches
Once SPS is correctly diagnosed, several treatment options are available:
Immune therapies: These may include plasma exchange (removing and replacing blood plasma) or intravenous immunoglobulin (IVIG) to modulate the immune response.
Muscle relaxants: Medications like diazepam can help reduce muscle stiffness and spasms.
Ongoing management: Regular follow-up and adjustment of treatments as needed are important for managing SPS long-term.
Living with Stiff-Person Syndrome
While SPS can be a challenging condition to live with, proper diagnosis and treatment can make a significant difference. The patient in this case study, for example, went from being unable to walk without a cane and living in fear of falling to being able to walk without difficulty after receiving appropriate treatment.
For individuals living with SPS, it’s important to:
Work closely with healthcare providers to manage symptoms and adjust treatments as needed
Be aware of potential triggers for muscle spasms and develop strategies to minimize their impact
Consider physical therapy or occupational therapy to improve mobility and daily functioning
Seek support from family, friends, or support groups for individuals with rare neurological conditions
Conclusions
- Stiff-person syndrome is a rare but significant neurological disorder that can greatly impact quality of life if left undiagnosed or untreated.
- Healthcare providers should consider SPS in patients presenting with characteristic muscle stiffness and spasms, even if initial signs point to other conditions.
- With proper diagnosis and treatment, many individuals with SPS can experience significant improvement in their symptoms and overall functioning.
By raising awareness of SPS and its potential for misdiagnosis, we can hope to improve outcomes for individuals living with this challenging condition.